[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Special safety probe at TEPCO gets under way



Index:



Special safety probe at TEPCO gets under way

EU says UK nuclear firm rescue illegal-paper

Study: No Cancer Jump Near Pa. Plant

U.S. Aides Sued Over Weapons Tests

Neb. Appeals Ruling in Nuke Lawsuit

MDS Nordion's MAPLE 1 Reactor Authorized for Low-power Commissioning

Rokkasho nuclear fuel reprocessing plant starts tests

===================================



Special safety probe at TEPCO gets under way



TOKYO, Nov. 5 (Kyodo) - The Nuclear and Industrial Safety Agency 

launched special safety inspections on Tuesday at Tokyo Electric 

Power Co.'s three nuclear plants as part of punitive administrative 

steps following a recent cover-up scandal.



The agency plans to carefully scrutinize the firm's safety measures, 

paying particular attention to its decision-making processes, 

internal-reporting practices and documentation methods, they said.



The inspections of the nation's largest utility could take as long as 

seven weeks, much longer than the quarterly inspections of about 

three weeks. The agency will also employ a larger number of 

inspectors than usual.



In late August, TEPCO was found to have covered up several reactor 

faults at the Fukushima No. 1 and No. 2 nuclear plants in Fukushima 

Prefecture and the Kashiwazaki-Kariwa plant in Niigata Prefecture.



Economy, Trade and Industry Minister Takeo Hiranuma, who oversees the 

agency, issued a five-point administrative measure on Oct. 1 designed 

to penalize the firm, along with a written warning to prevent a 

recurrence.

-------------------



EU says UK nuclear firm rescue illegal-paper



LONDON, Nov 2 (Reuters) - European Competition Commissioner Mario 

Monti has said in a letter that UK government aid to the privatised 

nuclear electricity firm British Energy Plc <BGY.L> is illegal, the 

Observer Sunday newspaper reported.



In the letter to a Green European legislator, the MEP Dr Caroline 

Lucas, Monti said the 650 million pound ($1.02 billion) rescue 

package that runs until November 29 "does constitute illegal aid 

since it was granted without proper authorisation", the newspaper 

reported.



British Energy, producer of more than one fifth of the UK's power, 

won the bailout from the government in September when it said it 

would otherwise become insolvent.



Electricity market liberalisation reforms in the UK that exposed 

industry overcapacity have sent electricity prices down below British 

Energy's cost of production

-------------------



Study: No Cancer Jump Near Pa. Plant



WASHINGTON Nov 2 (AP)  - People who live near the Three Mile Island 

nuclear plant show no significant increase in cancer deaths more than 

20 years after an accident at the plant released low amounts of 

radiation.



Researchers at the University of Pittsburgh studied deaths between 

1979 and 1998 among people who reside within five miles of the 

Pennsylvania plant. Their findings are reported on the Web site of 

the journal Environmental Health Perspectives.



``This survey of data, which covers the normal latency period for 

most cancers, confirms our earlier analysis that radioactivity 

released ... does not appear to have caused an overall increase in 

cancer deaths among residents of that area,'' principal investigator 

Evelyn Talbott said in a statement.



The researchers did note that overall deaths among the residents near 

the plant were higher than would have been expected, but most of the 

increase was the result of heart disease, not cancer.



The researchers looked at 32,135 people who lived near the plant at 

the time of the accident in 1979 and who were interviewed by the 

Pennsylvania Department of Health at the time.



The new findings are similar to those reported earlier in an analysis 

of the same population covering 13 years, except that an apparent 

increase in breast cancer at that time was no longer evident in the 

20-year study.



After adjusting for smoking, educational level and other factors, the 

researchers say there was no significant difference in the number of 

deaths in the plant area population compared with the expected number 

of deaths in the general population.



The researchers studied causes of death that included heart disease 

and cancers, in particular cancers known to be sensitive to 

radioactivity such as bronchial, throat and lung, breast, lymph 

system, blood-forming organs and the central nervous system.



The only elevated risk of cancer, they said, was a slight increase in 

the risk of lymphatic and blood cancers among men, which the 

researchers said was related to radiation exposure from the accident, 

and an increased risk of death from lymphatic and blood cancers in 

women, which they said was related to everyday background radiation 

exposure.



``While these findings overall convey good news for TMI residents, 

the slight increased risk of death from lymphatic and hematopoietic 

(blood) cancers may warrant further investigation,'' the team said in 

a statement.



On the Net:



Environmental Health Perspectives: http://www.ehponline.org

------------------



U.S. Aides Sued Over Weapons Tests



WASHINGTON  Oct 30 (AP) - Two groups of military veterans charge in 

federal court that they cannot get proper medical treatment because 

the government will not release records of their exposure to tests of 

atomic, chemical or biological weapons.



The suits say federal officials, dating to former Defense Secretary 

Robert McNamara, have refused to produce the records of weapons 

testing and details of whether the veterans were exposed to unsafe 

levels of radiation or toxic chemicals during experiments about which 

they were not told.



A spokesman for the Veterans Administration had no immediate comment 

Wednesday.



The suits, filed in U.S. District Court and announced Wednesday, 

cover 425,000 veterans.



``I wasn't asked if I wanted to be a human guinea pig,'' said one 

plaintiff, Robert Bates, a Navy veteran. ``And now, I can't get my 

complete medical records form the government so that I can get needed 

benefits.''



Lawyers for the veterans say government officials are failing to live 

up to their responsibilities.



Veterans Affairs spokesman Jim Benson said he could not comment on 

the lawsuits, but said the department had programs to treat veterans 

exposed to radiation and chemicals, and was studying long-term health 

effects.

--------------------



Neb. Appeals Ruling in Nuke Lawsuit



LINCOLN, Neb. Oct 31 (AP)  - The state on Wednesday appealed a 

federal judge's order that it pay $151 million for blocking 

construction of a dump for low-level radioactive waste.



The motion before the 8th Circuit Court of Appeals also asks for a 

chance to present the case to a jury.



In a Sept. 30 ruling, Judge Richard Kopf denied Nebraska's request 

for a jury trial, and said that former Gov. Ben Nelson, a Democrat 

who is now a U.S. senator, engaged in a politically motivated plot to 

keep the dump from being built in Nebraska.



Nebraska officials argued that they refused to license the dump 

because of concerns over possible pollution and a high water table at 

the proposed site near the South Dakota border.



The dump was to hold waste from Arkansas, Kansas, Louisiana, Nebraska 

and Oklahoma - which formed the Central Interstate Low-Level 

Radioactive Waste Compact in 1983.



On the Net:



Central Interstate Low Level Radioactive Waste Compact Commission: 

http://www.cillrwcc.org/



U.S. District Court for Nebraska: http://www.ned.uscourts.gov

-----------------



MDS Nordion's MAPLE 1 Reactor Authorized for Low-power Commissioning



This step advances process towards full commercial production of 

medical isotopes 



OTTAWA, CANADA, Oct. 29 /PRNewswire-FirstCall/ - MDS Nordion, the 

world's largest supplier of medical isotopes, announced today that a 

restart of low- power commissioning of its MAPLE 1 reactor in Chalk 

River, near Ottawa, has been authorized by the Canadian Nuclear 

Safety Commission (CNSC). The reactor is one of a pair that, along 

with an adjacent New Processing Facility, will, when fully 

operational, be capable of supplying more than 100% of the world's 

demand for the key isotopes used in a broad range of diagnostic and 

therapeutic medical applications.



"We have been looking forward to this restart of low-power 

commissioning because it represents the next concrete step in the 

process towards full commercial operation of MAPLE 1 and, eventually, 

its twin, MAPLE 2," said Iain Trevena, Senior Vice 

President, Nuclear Medicine at MDS Nordion. "These reactors will be 

the only ones in the world to be dedicated exclusively to the 

production of medical isotopes, and when they go fully online, they 

will help ensure the security of the global supply of these critical 

products that doctors rely on to help diagnose and treat cancers, 

brain disorders, heart disease and other illnesses for thousands of 

patients every day."



Atomic Energy of Canada Ltd. (AECL), which built and will operate the 

MAPLE facility on behalf of MDS Nordion, received CNSC 

authorization late last week to restart low-power commissioning of 

MAPLE 1, a process that had been interrupted in July 2000 when 

problems were encountered during testing of the reactor's shut-off 

rods. AECL has subsequently met a series of conditions set out 

by the CNSC as prerequisites to the restart of the process. Further 

authorizations to load fuel in the MAPLE 2 reactor and to start 

active commissioning of the New Processing Facility are expected to 

follow. Once all phases of commissioning are completed to the 

satisfaction of the CNSC, commercial production of medical isotopes 

in the MAPLE reactors and New Processing Facility will begin. 

In the meantime, AECL will continue to supply MDS Nordion with 

isotopes produced in its NRU reactor, also located at AECL's 

Chalk River Laboratories.



When fully operational, either of the two 10-megawatt MAPLE reactors 

will be able to supply in excess of 100% of the world's 

current demand for molybdenum-99, iodine-131 and xenon-133. Since the 

reactors that currently are being used for isotope 

production worldwide are all at least 35 years old, this back-up 

capability that has been established at Chalk River will ensure 

security of supply for the foreseeable future.



MAPLE is a pool-type reactor with a compact core of low-enriched 

uranium fuel surrounded by a heavy-water reflector vessel. The 

reactor is at the bottom of a light-water-filled pool that 

simultaneously provides shielding and cooling of the core. Novel 

processing 

facility technology complements the new reactors by providing a 

solidification process for the management of waste. The new 

process will generate only solid waste forms, and eliminate the need 

for long-term tank storage of liquid fissile waste.



"The MAPLE facility is a concrete example of MDS Nordion's commitment 

to nuclear medicine and our willingness to invest 

considerable resources in security of supply," said Dr. Trevena. 

"This latest advance in its progress is the result of the hard work 

and 

commitment to high quality and safety by our partners at AECL."

-------------------



Rokkasho nuclear fuel reprocessing plant starts tests



ROKKASHO, Japan, Nov. 1 (Kyodo) - A nuclear fuel reprocessing plant 

under construction in Rokkasho, Aomori Prefecture, began 

testing operations Friday, Japan Nuclear Fuel Ltd. (JNFL) officials 

said.



The JNFL, a consortium of nine electric power companies, the Japan 

Atomic Power Co. and 87 other companies, aims to start 

operating the plant in July 2005.



The facility will become Japan's first commercial plant to reprocess 

spent nuclear fuel for uranium and plutonium. The state and 

power companies, which have been promoting the technology, see 

facility as vital to their plans.



In the test, the JNFL used chemicals including nitric acid to confirm 

whether plant equipment functions as designed. Such 

chemicals will be used when the plant is under operation, JNFL 

officials said.



The JNFL planned to start the test around Sept. 18, but the schedule 

was delayed as it failed to reach an agreement with the village 

and the prefectural governments on protecting the area from 

radioactive contamination by that time.



The JFNL will start a test involving uranium around June 2003 and 

launch a so-called an ''active test'' involving spent nuclear fuel 

around July 2004.



The construction began in April 1993 and 90% of the work was 

completed by the end of September. The JNFL has conducted tests to 

check water and air flows at the plant since April 2001.



When the plant goes on line, it will reprocess about 800 tons of 

spent nuclear fuel per year, which will cover spent fuel from 30 

regular-sized reactors in the country.

-------------------------------------------------

Sandy Perle

Director, Technical

ICN Worldwide Dosimetry Service

ICN Plaza, 3300 Hyland Avenue

Costa Mesa, CA 92626



Tel:(714) 545-0100 / (800) 548-5100  Extension 2306

Fax:(714) 668-3149



E-Mail: sandyfl@earthlink.net

E-Mail: sperle@icnpharm.com



Personal Website: http://sandy-travels.com/

ICN Worldwide Dosimetry Website: http://www.dosimetry.com/



************************************************************************

You are currently subscribed to the Radsafe mailing list. To unsubscribe,

send an e-mail to Majordomo@list.vanderbilt.edu  Put the text "unsubscribe

radsafe" (no quote marks) in the body of the e-mail, with no subject line.

You can view the Radsafe archives at http://www.vanderbilt.edu/radsafe/